Investigating gaps in diagnosing and managing neuropathy in Black, low-income patients
Official title: The Flint Neuropathy Study: assessing diagnostic and management gaps in a Black, low-income population-supplement
Funded at University of Michigan at Ann Arbor · NIH-11178905 · Data updated 2026-11-12
This study is looking at how people in Flint, Michigan, especially those in Black, low-income communities, are diagnosed and treated for neuropathy, a painful condition, and aims to find better ways to help them get the care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | January 1, 2025 |
| Project end | June 30, 2025 |
| Funding year | 2025 |
| Award (this year) | $54,000 |
| NIH project number | 3K23NS131444-02S1 |
| Project ID | NIH-11178905 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Black, low-income individuals over the age of 40 who are experiencing symptoms of neuropathy.
✕Less likely to help
Patients who do not identify as Black or who are not part of the low-income demographic may not benefit from this research.
What this research studies
This research focuses on understanding how neuropathy, a painful and debilitating condition, is diagnosed and managed in Black, low-income populations, particularly in Flint, Michigan. The study aims to identify the significant gaps in diagnosis and treatment, as preliminary data shows that many patients remain undiagnosed. By utilizing computerized clinical decision support systems, the research seeks to improve the accuracy of diagnoses and the management of risk factors like obesity and hyperglycemia. The ultimate goal is to adapt and pilot an intervention that enhances the care provided to these patients, ensuring they receive appropriate treatment for their condition.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and management of neuropathy, enhancing the quality of life for affected patients.
How similar studies have gone: Previous research has shown that interventions using clinical decision support systems can effectively improve diagnosis and management in similar populations.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Elafros, Melissa — University of Michigan at Ann Arbor
- Study coordinator: Elafros, Melissa
Related research
Other NIH-funded projects on the same topics.
-
Non-invasive, microscopic biomarkers to detect CIPN in chemotherapy patients
This grant aims to develop a non-invasive imaging method to measure nerve changes in patients undergoing chemotherapy to better understand and monitor chemotherapy-induced peripheral neuropathy (CIPN).
-
Neonatal Fc receptor blockade by efgartigimod to help inflammatory nerve disease
Aims to test how blocking a specific antibody trafficking receptor with efgartigimod could improve nerve inflammation in a model of AIDP/GBS-type neuropathy.
-
Schwann cell aging and secretions linked to diabetic nerve damage
A research project looking at how aging nerve cells and their secretions may drive nerve damage in people with type 2 diabetes.
-
Diabetic bladder problems in diabetes mice show sex-specific nerve and inflammation roles
Aims to understand why bladder problems happen in diabetes, exploring how inflammation and nerves differ between male and female mice.
-
Prenyltransferase inhibitor as a new therapy for inflammatory neuropathy
A new drug candidate called FGTI-2734 is being studied to calm nerve inflammation in conditions like AIDP/Guillain-Barré syndrome, with the goal of protecting nerves and reducing symptoms.
-
KCTD11-related CMT neuropathy: uncovering how it damages nerves
We are studying a genetic form of Charcot–Marie–Tooth disease to understand what goes wrong in nerves and support future treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.